The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
RMS13: A phase II trial using risk adapted focal proton beam radiation and/or surgery with the addition of maintenance chemotherapy in intermediate risk rhabdomyosarcoma.
 
Jessica Gartrell
No Relationships to Disclose
 
Alberto S. Pappo
Honoraria - Bayer; Lilly; Pfizer; Roche
Consulting or Advisory Role - Debbio; EUSA Pharma; Lilly; Loxo/Bayer; Merck; Pfizer
 
Yimei Li
No Relationships to Disclose
 
Tushar Patni
No Relationships to Disclose
 
Daniel J. Indelicato
No Relationships to Disclose
 
Sara Michele Federico
No Relationships to Disclose
 
Elizabeth Stewart
No Relationships to Disclose
 
Christopher L Tinkle
No Relationships to Disclose
 
Sara Helmig
No Relationships to Disclose
 
John Thomas Lucas
No Relationships to Disclose
 
Michael W. Bishop
Consulting or Advisory Role - Exelixis
Travel, Accommodations, Expenses - Exelixis
 
Mary B McCarville
No Relationships to Disclose
 
Karen H. Albritton
No Relationships to Disclose
 
Matthew J. Krasin
No Relationships to Disclose